Phase
Condition
Rhinitis, Allergic, Perennial
Acute Rhinitis
Allergy (Pediatric)
Treatment
N/AClinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
A clinical history of grass pollen-induced allergic rhinoconjunctivitis (with orwithout asthma) having received treatment during the previous grass pollen season.
Positive skin prick test (SPT) response (wheal diameter ≥3mm) to Phleum pratense
Positive specific IgE against Phleum pratense (IgE titer > class 2)
Exclusion
Exclusion Criteria:
Clinical history of chronic sinusitis during the last 2 years or of symptomaticperennial or seasonal allergic rhinitis and/or asthma having received regularmedication, due to another allergen during - or potentially overlapping - the grasspollen season.
Clinical history of severe asthma (GINA Step 4 and children with Forced ExpiratoryVolume in 1 second (FEV1) < 80% of expected value after treatment with inhaledcorticosteroids and short-acting β2 agonists)
Previous treatment by immunotherapy with grass pollen allergen or any other allergenwithin the previous 5 years
Study Design
Connect with a study center
Fondazione IRCCS Policlinico San Matteo
Pavia, PV 27100
ItalySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.